Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells

Journal of Leukocyte Biology

Volumn 82, Issue 6, 2007, Pages 1473-1480

  Lin, Yu Li ^a,b   Liang, Yu Chih ^c   Chiang, Bor Luen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Signal transduction; T cells; Th1 Th2 cells

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; INTERLEUKIN 5; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TH1 CELL; UPREGULATION;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL POLARITY; CELL PROLIFERATION; CELLS, CULTURED; CROSS-PRIMING; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; NF-KAPPA B; PREGNANCY PROTEINS; TH1 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 37249055916     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0307164     Document Type: Article

References (30)

1. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
2. Cella, M., Sallusto, F., Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16.
3. Cella, M., Engering, A., Pinet, V., Pieters, J., Lanzavecchia, A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787.
4. Sallusto, F., Cella, M., Danieli, C., Lanzavecchia, A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400.
5. Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., Vogel, J. C. (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042-3049.
6. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
7. Yoshimura, S., Bondeson, J., Foxwell, B. M., Brennan, F. M., Feldmann, M. (2001) Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 13, 675-683.
8. Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P., Persico, M. G. (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA 88, 9267-9271.
9. Zachary, I. (2001) Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am. J. Physiol. Cell Physiol. 280, C1375-C1386.
10. Tammela, T., Enholm, B., Alitalo, K., Paavonen, K. (2005) The biology of vascular endothelial growth factors. Cardiovasc. Res. 65, 550-563.
11. Maglione, D., Guerriero, V., Rambaldi, M., Russo, G., Persico, M. G. (1993) Translation of the placenta growth factor mRNA is severely affected by a small open reading frame localized in the 5′ untranslated region. Growth Factors 8, 141-152.
12. Takahashi, A., Sasaki, H., Kim, S. J., Tobisu, K., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., Terada, M. (1994) Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 54, 4233-4237.
13. Matsumoto, K., Suzuki, K., Koike, H., Okamura, K., Tsuchiya, K., Uchida, T., Takezawa, Y., Kobayashi, M., Yamanaka, H. (2003) Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res. 23, 4953-4958.
14. Zhou, L. J., Tedder, T. F. (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2588-2592.
15. Lin, Y. L., Liang, Y. C., Lee, S. S., Chiang, B. L. (2005) Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-κB and p38 mitogen-activated protein kinase pathways. J. Leukoc. Biol. 78, 533-543.
16. Lin, Y. L., Lin, J. K. (1997) (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 52, 465-472.
17. Chaux, P., Favre, N., Martin, M., Martin, F. (1997) Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 72, 619-624.
18. Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., Carbone, D. P. (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3, 483-490.
19. Trinchieri, G. (1998) Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83-243.
20. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
21. Arrighi, J. F., Rebsamen, M., Rousset, F., Kindler, V., Hauser, C. (2001) A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J. Immunol. 166, 3837-3845.
22. Miyamoto, S., Verma, I. M. (1995) Rel/NF-κ B/I κ B story. Adv. Cancer Res. 66, 255-292.
23. Kopp, E. B., Ghosh, S. (1995) NF-κ B and rel proteins in innate immunity. Adv. Immunol. 58, 1-27.
24. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
25. Folkman, J. (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763.
26. Parr, C., Watkins, G., Boulton, M., Cai, J., Jiang, W. G. (2005) Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur. J. Cancer 41, 2819-2827.
27. Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., Gabrilovich, D. I. (1998) Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κ B activation in hemopoietic progenitor cells. J. Immunol. 160, 1224-1232.
28. Zygmunt, M., Herr, F., Munstedt, K., Lang, U., Liang, O. D. (2003) Angiogenesis and vasculogenesis in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 110 (Suppl. 1), S10-S18.
29. Miyaura, H., Iwata, M. (2002) Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 168, 1087-1094.
30. Hahn-Zoric, M., Hagberg, H., Kjellmer, I., Ellis, J., Wennergren, M., Hanson, L. A. (2002) Aberrations in placental cytokine mRNA related to intrauterine growth retardation. Pediatr. Res. 51, 201-206.